Cargando…
A profile of transcriptomic changes in the rd10 mouse model of retinitis pigmentosa
PURPOSE: Retinitis pigmentosa (RP) is a photoreceptor disease that affects approximately 100,000 people in the United States. Treatment options are limited, and the prognosis for most patients is progressive vision loss. Unfortunately, understanding of the molecular underpinnings of RP initiation an...
Autores principales: | Uren, Philip J., Lee, Justine T., Doroudchi, M. Mehdi, Smith, Andrew D., Horsager, Alan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Vision
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4235044/ https://www.ncbi.nlm.nih.gov/pubmed/25489233 |
Ejemplares similares
-
Electrophysiological and Histologic Evaluation of the Time Course of Retinal Degeneration in the rd10 Mouse Model of Retinitis Pigmentosa
por: Jae, Seol A, et al.
Publicado: (2013) -
Novel VCP modulators mitigate major pathologies of rd10, a mouse model of retinitis pigmentosa
por: Ikeda, Hanako Ohashi, et al.
Publicado: (2014) -
The synthetic progestin norgestrel acts to increase LIF levels in the rd10 mouse model of retinitis pigmentosa
por: Byrne, Ashleigh M., et al.
Publicado: (2016) -
Modulation of GSK-3 provides cellular and functional neuroprotection in the rd10 mouse model of retinitis pigmentosa
por: Sánchez-Cruz, Alonso, et al.
Publicado: (2018) -
Carnosic acid slows photoreceptor degeneration in the Pde6b(rd10) mouse model of retinitis pigmentosa
por: Kang, Kai, et al.
Publicado: (2016)